Cargando…

The In Vivo Selection Method in Breast Cancer Metastasis

Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Jun, Han, Yuxuan, Kuroiwa, Yuka, Azuma, Kazushi, Yamamoto, Yusuke, Semba, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918415/
https://www.ncbi.nlm.nih.gov/pubmed/33672831
http://dx.doi.org/10.3390/ijms22041886
_version_ 1783657917392617472
author Nakayama, Jun
Han, Yuxuan
Kuroiwa, Yuka
Azuma, Kazushi
Yamamoto, Yusuke
Semba, Kentaro
author_facet Nakayama, Jun
Han, Yuxuan
Kuroiwa, Yuka
Azuma, Kazushi
Yamamoto, Yusuke
Semba, Kentaro
author_sort Nakayama, Jun
collection PubMed
description Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The in vivo selection method and highly metastatic cancer cell lines have contributed to reveal the molecular mechanisms of cancer metastasis. Here, we present an overview of the methodology for the in vivo selection method. Recent comparative analysis of the transplantation methods for metastasis have revealed the divergence of metastasis gene signatures. Even cancer cells that metastasize to the same organ show various metastatic cascades and gene expression patterns by changing the transplantation method for the in vivo selection. These findings suggest that the selection of metastasis models for the study of metastasis gene signatures has the potential to influence research results. The study of novel gene signatures that are identified from novel highly metastatic cell lines and patient-derived xenografts (PDXs) will be helpful for understanding the novel mechanisms of metastasis.
format Online
Article
Text
id pubmed-7918415
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79184152021-03-02 The In Vivo Selection Method in Breast Cancer Metastasis Nakayama, Jun Han, Yuxuan Kuroiwa, Yuka Azuma, Kazushi Yamamoto, Yusuke Semba, Kentaro Int J Mol Sci Review Metastasis is a complex event in cancer progression and causes most deaths from cancer. Repeated transplantation of metastatic cancer cells derived from transplanted murine organs can be used to select the population of highly metastatic cancer cells; this method is called as in vivo selection. The in vivo selection method and highly metastatic cancer cell lines have contributed to reveal the molecular mechanisms of cancer metastasis. Here, we present an overview of the methodology for the in vivo selection method. Recent comparative analysis of the transplantation methods for metastasis have revealed the divergence of metastasis gene signatures. Even cancer cells that metastasize to the same organ show various metastatic cascades and gene expression patterns by changing the transplantation method for the in vivo selection. These findings suggest that the selection of metastasis models for the study of metastasis gene signatures has the potential to influence research results. The study of novel gene signatures that are identified from novel highly metastatic cell lines and patient-derived xenografts (PDXs) will be helpful for understanding the novel mechanisms of metastasis. MDPI 2021-02-14 /pmc/articles/PMC7918415/ /pubmed/33672831 http://dx.doi.org/10.3390/ijms22041886 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nakayama, Jun
Han, Yuxuan
Kuroiwa, Yuka
Azuma, Kazushi
Yamamoto, Yusuke
Semba, Kentaro
The In Vivo Selection Method in Breast Cancer Metastasis
title The In Vivo Selection Method in Breast Cancer Metastasis
title_full The In Vivo Selection Method in Breast Cancer Metastasis
title_fullStr The In Vivo Selection Method in Breast Cancer Metastasis
title_full_unstemmed The In Vivo Selection Method in Breast Cancer Metastasis
title_short The In Vivo Selection Method in Breast Cancer Metastasis
title_sort in vivo selection method in breast cancer metastasis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918415/
https://www.ncbi.nlm.nih.gov/pubmed/33672831
http://dx.doi.org/10.3390/ijms22041886
work_keys_str_mv AT nakayamajun theinvivoselectionmethodinbreastcancermetastasis
AT hanyuxuan theinvivoselectionmethodinbreastcancermetastasis
AT kuroiwayuka theinvivoselectionmethodinbreastcancermetastasis
AT azumakazushi theinvivoselectionmethodinbreastcancermetastasis
AT yamamotoyusuke theinvivoselectionmethodinbreastcancermetastasis
AT sembakentaro theinvivoselectionmethodinbreastcancermetastasis
AT nakayamajun invivoselectionmethodinbreastcancermetastasis
AT hanyuxuan invivoselectionmethodinbreastcancermetastasis
AT kuroiwayuka invivoselectionmethodinbreastcancermetastasis
AT azumakazushi invivoselectionmethodinbreastcancermetastasis
AT yamamotoyusuke invivoselectionmethodinbreastcancermetastasis
AT sembakentaro invivoselectionmethodinbreastcancermetastasis